AstraZeneca plc vs Tenet Healthcare Corporation — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: AstraZeneca plc is far larger — about 11.9× Tenet Healthcare Corporation's market cap, and AstraZeneca plc pays a 2.01% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| AZN | THC | |
|---|---|---|
Market Cap | $248.14B | $20.89B |
Sector | Health | Health |
52-Week High | $209.48 | $262.63 |
52-Week Low | $147.06 | $161.37 |
Enterprise Value | $275.41B | $31.97B |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →